176 related articles for article (PubMed ID: 36293074)
61. Leukotriene E(4)-induced persistent eosinophilia and airway obstruction are reversed by zafirlukast in patients with asthma.
Laitinen A; Lindqvist A; Halme M; Altraja A; Laitinen LA
J Allergy Clin Immunol; 2005 Feb; 115(2):259-65. PubMed ID: 15696079
[TBL] [Abstract][Full Text] [Related]
62. Treatment of experimental human breast cancer and lung cancer brain metastases in mice by macitentan, a dual antagonist of endothelin receptors, combined with paclitaxel.
Lee HJ; Hanibuchi M; Kim SJ; Yu H; Kim MS; He J; Langley RR; Lehembre F; Regenass U; Fidler IJ
Neuro Oncol; 2016 Apr; 18(4):486-96. PubMed ID: 26995790
[TBL] [Abstract][Full Text] [Related]
63. Pharmacology of leukotriene receptor antagonists.
Aharony D
Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 2):S214-8; discussion S218-9, S247-8. PubMed ID: 9647602
[TBL] [Abstract][Full Text] [Related]
64. Zafirlukast: an update of its pharmacology and therapeutic efficacy in asthma.
Dunn CJ; Goa KL
Drugs; 2001; 61(2):285-315. PubMed ID: 11270943
[TBL] [Abstract][Full Text] [Related]
65. Zafirlukast. A review of its pharmacology and therapeutic potential in the management of asthma.
Adkins JC; Brogden RN
Drugs; 1998 Jan; 55(1):121-44. PubMed ID: 9463793
[TBL] [Abstract][Full Text] [Related]
66. Platelet glycoprotein VI promotes metastasis through interaction with cancer cell-derived galectin-3.
Mammadova-Bach E; Gil-Pulido J; Sarukhanyan E; Burkard P; Shityakov S; Schonhart C; Stegner D; Remer K; Nurden P; Nurden AT; Dandekar T; Nehez L; Dank M; Braun A; Mezzano D; Abrams SI; Nieswandt B
Blood; 2020 Apr; 135(14):1146-1160. PubMed ID: 32040544
[TBL] [Abstract][Full Text] [Related]
67. Comparison of the bronchodilating effect of salmeterol and zafirlukast in combination with that of their use as single treatments in asthma and chronic obstructive pulmonary disease.
Cazzola M; Centanni S; Boveri B; Di Marco F; Santus P; Matera MG; Allegra L
Respiration; 2001; 68(5):452-9. PubMed ID: 11694805
[TBL] [Abstract][Full Text] [Related]
68. Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, enhances radiosensitivity and suppresses lung metastasis in breast cancer in vitro and in vivo.
Chiu HW; Yeh YL; Wang YC; Huang WJ; Chen YA; Chiou YS; Ho SY; Lin P; Wang YJ
PLoS One; 2013; 8(10):e76340. PubMed ID: 24130769
[TBL] [Abstract][Full Text] [Related]
69. Temporal inhibition of mouse mammary gland cancer metastasis by CORM-A1 and DETA/NO combination therapy.
Porshneva K; Papiernik D; Psurski M; Łupicka-Słowik A; Matkowski R; Ekiert M; Nowak M; Jarosz J; Banach J; Milczarek M; Goszczyński TM; Sieńczyk M; Wietrzyk J
Theranostics; 2019; 9(13):3918-3939. PubMed ID: 31281522
[TBL] [Abstract][Full Text] [Related]
70. Downregulation of Integrins in Cancer Cells and Anti-Platelet Properties Are Involved in Holothurian Glycosaminoglycan-Mediated Disruption of the Interaction of Cancer Cells and Platelets in Hematogenous Metastasis.
Qian W; Tao L; Wang Y; Zhang F; Li M; Huang S; Wang A; Chen W; Yue Z; Chen L; Liu Y; Huang C; Zhang L; Li Y; Lu Y
J Vasc Res; 2015; 52(3):197-209. PubMed ID: 26488158
[TBL] [Abstract][Full Text] [Related]
71. Overexpression of cysteinyl LT1 receptor in prostate cancer and CysLT1R antagonist inhibits prostate cancer cell growth through apoptosis.
Matsuyama M; Hayama T; Funao K; Kawahito Y; Sano H; Takemoto Y; Nakatani T; Yoshimura R
Oncol Rep; 2007 Jul; 18(1):99-104. PubMed ID: 17549353
[TBL] [Abstract][Full Text] [Related]
72. Evaluation of a CXCR4 antagonist in a xenograft mouse model of inflammatory breast cancer.
Singh B; Cook KR; Martin C; Huang EH; Mosalpuria K; Krishnamurthy S; Cristofanilli M; Lucci A
Clin Exp Metastasis; 2010 Apr; 27(4):233-40. PubMed ID: 20229045
[TBL] [Abstract][Full Text] [Related]
73. New perspectives for asthma treatment: anti-leukotriene drugs.
García-Marcos L; Schuster A
Pediatr Allergy Immunol; 1999 May; 10(2):77-88. PubMed ID: 10478608
[TBL] [Abstract][Full Text] [Related]
74. Concentration-dependent noncysteinyl leukotriene type 1 receptor-mediated inhibitory activity of leukotriene receptor antagonists.
Woszczek G; Chen LY; Alsaaty S; Nagineni S; Shelhamer JH
J Immunol; 2010 Feb; 184(4):2219-25. PubMed ID: 20083671
[TBL] [Abstract][Full Text] [Related]
75. Summary of clinical trials with zafirlukast.
Calhoun WJ
Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 1):S238-46. PubMed ID: 9620946
[TBL] [Abstract][Full Text] [Related]
76. Nitric oxide deficiency and endothelial-mesenchymal transition of pulmonary endothelium in the progression of 4T1 metastatic breast cancer in mice.
Smeda M; Kieronska A; Adamski MG; Proniewski B; Sternak M; Mohaissen T; Przyborowski K; Derszniak K; Kaczor D; Stojak M; Buczek E; Jasztal A; Wietrzyk J; Chlopicki S
Breast Cancer Res; 2018 Aug; 20(1):86. PubMed ID: 30075800
[TBL] [Abstract][Full Text] [Related]
77. Hippocampal CysLT
Lin JR; Fang SC; Tang SS; Hu M; Long Y; Ghosh A; Sun HB; Kong LY; Hong H
Acta Pharmacol Sin; 2017 Apr; 38(4):477-487. PubMed ID: 28112182
[TBL] [Abstract][Full Text] [Related]
78. Effects of blocking platelet-derived growth factor-receptor signaling in a mouse model of experimental prostate cancer bone metastases.
Uehara H; Kim SJ; Karashima T; Shepherd DL; Fan D; Tsan R; Killion JJ; Logothetis C; Mathew P; Fidler IJ
J Natl Cancer Inst; 2003 Mar; 95(6):458-70. PubMed ID: 12644539
[TBL] [Abstract][Full Text] [Related]
79. Montelukast and zafirlukast do not affect the pharmacokinetics of the CYP2C8 substrate pioglitazone.
Jaakkola T; Backman JT; Neuvonen M; Niemi M; Neuvonen PJ
Eur J Clin Pharmacol; 2006 Jul; 62(7):503-9. PubMed ID: 16670899
[TBL] [Abstract][Full Text] [Related]
80. pH-Responsive Wormlike Micelles with Sequential Metastasis Targeting Inhibit Lung Metastasis of Breast Cancer.
He X; Yu H; Bao X; Cao H; Yin Q; Zhang Z; Li Y
Adv Healthc Mater; 2016 Feb; 5(4):439-48. PubMed ID: 26711864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
